Widespread xanthomas regression by personalized lipid lowering therapy in heterozygous familial hypercholesterolemia

Area of Science:

• Cardiology
• Metabolic Disorders
• Dermatology

Background:

• High LDL cholesterol management typically follows a "lower, the better" approach.
• Severe hypercholesterolemia can present with significant clinical manifestations like xanthomas.

Observation:

• A 69-year-old woman presented with extremely high LDL cholesterol (412 mg/dL).
• She also had bilateral xanthelasma and extensive cutaneous xanthomas.

Findings:

• A combination of maximized and personalized lipid-lowering therapies was initiated.
• These included rosuvastatin, ezetimibe, PCSK9 inhibitors, and lipoprotein apheresis.
• After six months, the patient demonstrated impressive regression of cutaneous xanthomas.

Implications:

• This case underscores the efficacy of intensive, multi-modal treatment for severe hypercholesterolemia.
• Aggressive lipid management can lead to significant clinical improvement and regression of xanthomatous lesions.
• Personalized therapeutic strategies are crucial for managing complex lipid disorders.